We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 406.70
Bid: 425.00
Ask: 389.60
Change: 5.70 (1.42%)
Spread: -35.40 (-8.329%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 401.00
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition, CDC Contract Win and Trading Update

7 Jul 2016 07:00

RNS Number : 4823D
Rentokil Initial PLC
07 July 2016
 

 

7 July 2016

Acquisition, CDC Contract Win and Trading Update

Rentokil acquires Residex

Rentokil Initial plc (FTSE: RTO, "the Company") announces its continued expansion in North America with the acquisition of pest control and turf products distribution business Residex LLC ("Residex") for US$30m.

Residex is the largest independent products distribution company in the US, with annualised revenues for the 12 months prior to acquisition of $113m. The acquisition increases the scale of the Company's existing pest and turf products business, which more than doubles in size. It creates the second largest business of this type in the US market, delivering national coverage and a greater density footprint.

Andy Ransom, Chief Executive of Rentokil Initial plc, said: "I'm delighted to welcome the Residex team to Rentokil Initial. North America is a strategic growth market for Rentokil with great potential for continued profitable growth and our acquisition pipeline remains strong. The addition of Residex means that our business in North America is set to deliver annualised revenues of around $1 billion by the end of the year - some two years ahead of our expectations."

In the first half of 2016 the Company completed a series of 20 highly-targeted city-based acquisitions, predominantly in Pest Control in North America, Asia, Pacific and Europe. Total annualised revenues in the year prior to acquisition for these businesses acquired, including Residex, were c. £100m.

Rentokil wins two-year contract with the US government to combat Zika virus

Rentokil North America has been awarded a contract by the U.S. Centers for Disease Control and Prevention ("CDC") to help control the species of mosquito that could potentially carry the Zika virus across the USA and its protectorates. The requirement of the programme is to provide pest control services until June 2018, subject to government review. As required, Rentokil will deploy its network of more than 4,000 pest control experts alongside its global technical resource to target affected or high-risk areas. Additionally, a key component of the contract includes support services that entail community outreach, surveillance and inspection, and support for the distribution of materials and educational information.

Andy Ransom, Chief Executive of Rentokil Initial plc, said: "I'm proud that Rentokil has been selected to support the work of the CDC throughout the USA. Across the world we combat the dangers to public health from mosquitoes such as Dengue fever in Asia, to Malaria and West Nile virus in Africa and the Americas. Our depth of expertise and experience in global mosquito control is simply unmatched."

Trading update

Following its First Quarter trading announcement on 20 April the Company has continued to perform well and our expectations for 2016 at constant exchange rates remain unchanged.

In respect of the outcome of the EU Referendum and the UK's decision to leave the EU, we advise that approximately 90% of the Company's revenues are derived from outside the UK and there is minimal cross-border trading across its global businesses. Sterling has weakened significantly since the announcement and, if recent rates were to prevail for the remainder of the year, the estimated favourable impact of currency movements on our profit for 2016 would be in the range of £25m to £30m. This would be an increase of £10m to £15m on the guidance previously given at the time of our Preliminary results.

We also note that on 29 June 2016, Standard & Poor's removed its negative outlook from the Company's BBB debt rating, reflecting continued good progress in the execution of the Steritech integration.

 

The Company will provide more details on its H1 performance and its prospects for the remainder of 2016 at its Interim Results on 28 July 2016.

 

Notes to Editors

 

About Rentokil Initial plc

Rentokil Initial is one of the largest business services companies in the world, operating in over 60 countries. The Company offers route-based services including Pest Control, Hygiene and Workwear through teams of local experts.

 

About Products Distribution

 

The Company's existing Target Specialty Products business is a leading US national wholesale distributor of specialty agricultural chemicals, application equipment, products, supplies, services and education. It provides products and services to both private and public sector industries including structural pest control, landscape construction and maintenance, golf course maintenance and turfgrass maintenance, production nursery, industrial vegetation management, aquatic, forestry and vector control.

 

Residex LLC is a Michigan headquartered pest products and turf management products distribution company. It was founded in 1946 and in 2010 it merged with Turfgrass, adding turf products to Residex's predominantly pest products business. Today the company's sales are approximately 50 per cent pest products and 50 per cent turf products. It sells its products throughout the US and Canada with a particular focus on the Midwest, South East and North East US.

 

 

Enquiries:

 

Investor / Analyst enquiries: Katharine Rycroft, Investor Relations, Rentokil Initial plc: 07811 270 734

Media enquiries: Malcolm Padley, Corporate Communications, Rentokil Initial plc: 07788 978 199 Ben Woodford / Sam Cartwright, Bell Pottinger: 0203 772 2566

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUGUBUMUPQPGQ
Date   Source Headline
12th Oct 20124:06 pmRNSHolding(s) in Company
10th Oct 20125:13 pmRNSHolding(s) in Company
9th Oct 201210:27 amRNSRedemption of Floating Rate Reset Notes
25th Sep 20127:00 amRNSAcquisition
21st Sep 20122:00 pmRNSHolding(s) in Company
20th Sep 20125:38 pmRNSPublication of Prospectus
20th Sep 20122:12 pmRNSHolding(s) in Company
17th Sep 20123:15 pmRNSIssue of new EUR 500m bond
14th Sep 20125:32 pmRNSPublication of Prospectus
14th Sep 20122:45 pmRNSHolding(s) in Company
17th Aug 201211:49 amRNSAmendment-Interim Results to 30.06.12
6th Aug 20125:20 pmRNSAcquisition
3rd Aug 20127:00 amRNSInterim Results for six months to 30.06.12
31st Jul 20123:52 pmRNSHolding(s) in Company
28th Jun 20129:23 amRNSDirector/PDMR Shareholding
9th May 20126:09 pmRNSAMENDING RNS released 16:51 - 09.05.12
9th May 20124:51 pmRNSDirector/PDMR Shareholding
8th May 20127:00 amRNSDirector/PDMR Shareholding
4th May 20127:00 amRNSInterim Management Statement - Q1
2nd May 20121:24 pmRNSResult of AGM
10th Apr 201210:39 amRNSPublication of Prospectus
29th Mar 20129:20 amRNSAnnual Financial Report
19th Mar 20123:58 pmRNSDirector/PDMR Shareholding
2nd Mar 201211:37 amRNSDividend - Record date amendment
2nd Mar 20127:00 amRNSFinal Results
24th Feb 20127:00 amRNSDirectorate Change
7th Feb 201211:48 amRNSHolding(s) in Company
3rd Feb 20124:37 pmRNSHolding(s) in Company
13th Jan 20129:41 amRNSHolding(s) in Company
6th Jan 20125:21 pmRNSHolding(s) in Company
21st Dec 20114:37 pmRNSHolding(s) in Company
5th Dec 20115:01 pmRNSAcquisition of MSS Facilities Management
30th Nov 20114:31 pmRNSHolding(s) in Company
28th Nov 20115:05 pmRNSHolding(s) in Company
21st Nov 20117:00 amRNSProposed acquisition of building services division
18th Nov 201112:49 pmRNSHolding(s) in Company
14th Nov 20119:32 amRNSHolding(s) in Company
11th Nov 20114:29 pmRNSHolding(s) in Company
7th Nov 20117:00 amRNSTrading update for 3rd quarter ended 30.09.11
17th Oct 20112:58 pmRNSHolding(s) in Company
12th Oct 20113:25 pmRNSHolding(s) in Company
5th Oct 20111:59 pmRNSHolding(s) in Company
5th Oct 201111:59 amRNSHolding(s) in Company
23rd Sep 20119:49 amRNSHolding(s) in Company
11th Aug 20118:30 amRNSDirector/PDMR Shareholding
10th Aug 20114:14 pmRNSHolding(s) in Company
3rd Aug 20111:58 pmRNSDirector/PDMR Shareholding
2nd Aug 20114:32 pmRNSHolding(s) in Company
29th Jul 20117:00 amRNSInterim results for six months to 30 June 2011
20th Jul 20117:00 amRNSMulti Country Contract with Rentokil

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.